Bristol-Myers Goes After Celgene

Bristol-Myers to Buy Celgene

Bristol-Myers Squibb is making a $74 billion bet — and investors aren't pleased. The New York-based pharmaceutical giant on Thursday said it would acquire Celgene, a Summit, New Jersey-based cancer drug company, in a cash and stock deal valued at $74 billion...

By | January, 4, 2019|Categories: Articles, Featured|Tags: , , , , , , , |0 Comments

Pepsi Please

PepsiCo to Buy SodaStream

Beverage and snack giant PepsiCo announced plans Monday to acquire at-home carbonated drink maker SodaStream for $3.2 billion. Purchase, New York-based PepsiCo agreed to pay $144 per share in cash for SodaStream's outstanding stock, a 32 percent premium to its 30-day volume weighted average price...

By | August, 21, 2018|Categories: Articles, Featured|Tags: , , , , |0 Comments